Investigational Drug Service: Maintaining Consistency in a Dynamic Field
March 20, 2019
12:30–1:30 pm EST / 11:30–12:30 pm CDT
This webinar is also part of the 2019 ACPE Webinar Bundle
Statement of Need/Activity Purpose
Pharmaceutical companies and their investigational products can be expected to change with relative frequency. Investigational pharmacies should prepare for this change and develop strategies to manage it efficiently. This presentation will discuss strategies to maintain standard practices that facilitate reproducible, accurate results in an evolving system.
- Describe the importance of streamlining and standardization of operations and procedures.
- Explore alternatives to traditional protocol binders.
- Examine the fundamentals of a successful IDS workforce.
Krista Wolf, PharmD
Supervisor, Investigational Drug Service at Oregon Health and Science University
Krista Wolf received a Bachelor of Science in molecular cellular biology from the University of Illinois at Urbana-Champaign in 2005 and a PharmD degree from the University of Illinois at Chicago in 2010. She subsequently completed a PGY-1 pharmacy practice residency at the University of Illinois at Chicago. She began work as an Investigational Drug Service pharmacist in 2012 at the University of Colorado Hospital Anschutz Cancer Pavilion. In 2015 she became supervisor of the Investigational Drug Service at Oregon Health and Science University.
This activity is intended for Hematology/Oncology pharmacists. This activity has been approved for 1.00 contact hours (.10CEUs) under the ACPE universal activity number # 0465-0000-19-055-H04-P.
HOPA Member ‒ $20
Nonmember ‒ $40
The Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. A statement of credit will be issued only upon completion of the post-activity evaluation form and post-test.
Handouts for the webinar will be available through My Education Library 1-2 days prior to the webinar.